Clinical and experimental treatment of type 1 diabetes
- PMID: 35980300
- DOI: 10.1093/cei/uxac077
Clinical and experimental treatment of type 1 diabetes
Abstract
Type 1 diabetes (T1D) is an autoimmune disease resulting in the destruction of the insulin-producing pancreatic beta cells. Disease progression occurs along a trajectory from genetic risk, the development of islet autoantibodies, and autoreactive T cells ultimately progressing to clinical disease. Natural history studies and mechanistic studies linked to clinical trials have provided insight into the role of the immune system in disease pathogenesis. Here, we review our current understanding of the underlying etiology of T1D, focusing on the immune cell types that have been implicated in progression from pre-symptomatic T1D to clinical diagnosis and established disease. This knowledge has been foundational for the development of immunotherapies aimed at the prevention and treatment of T1D.
Keywords: autoantibodies; autoimmunity; cellular immunology; diabetes; immunotherapy.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology.
Similar articles
-
Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.Front Endocrinol (Lausanne). 2020 Oct 19;11:591083. doi: 10.3389/fendo.2020.591083. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33193102 Free PMC article. Review.
-
Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Rheum Dis Clin North Am. 2014 Nov;40(4):797-811. doi: 10.1016/j.rdc.2014.07.008. Epub 2014 Sep 2. Rheum Dis Clin North Am. 2014. PMID: 25437293 Free PMC article. Review.
-
Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis.Front Immunol. 2021 Oct 7;12:756548. doi: 10.3389/fimmu.2021.756548. eCollection 2021. Front Immunol. 2021. PMID: 34691077 Free PMC article. Review.
-
Role of innate immunity in triggering and tuning of autoimmune diabetes.Curr Mol Med. 2009 Feb;9(1):30-44. doi: 10.2174/156652409787314471. Curr Mol Med. 2009. PMID: 19199940 Review.
-
The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children.Int J Mol Sci. 2021 Jul 13;22(14):7493. doi: 10.3390/ijms22147493. Int J Mol Sci. 2021. PMID: 34299114 Free PMC article. Review.
Grant support
LinkOut - more resources
Full Text Sources